舌下神经刺激对阻塞性睡眠呼吸暂停患者缺氧负荷的影响:STAR试验二次分析
该研究为STAR试验的二次分析,纳入108例中重度OSA且不耐受PAP治疗的成人。舌下神经刺激治疗12个月后,缺氧负荷中位降低76.6%,高缺氧负荷组中81.5%转为低负荷;日间嗜睡改善与缺氧负荷降低相关,而与AHI或觉醒指数变化无关。
要点
- 舌下神经刺激可显著降低OSA患者的缺氧负荷。
- 日间嗜睡改善与缺氧负荷降低相关,而非AHI变化。
- 部分AHI无应答者仍显示缺氧负荷明显改善。
核心结论
- 舌下神经刺激治疗与OSA患者缺氧负荷降低显著相关。
- 日间嗜睡改善与缺氧负荷降低相关,而与AHI或觉醒指数变化无关。
- 至少半数AHI无应答者显示缺氧负荷明显改善,提示缺氧负荷可作为评估治疗反应的补充生理标志物。
研究设计与样本
- STAR试验的二次分析,多中心非随机试验含随机撤药研究,2010年11月10日至2013年3月23日进行。
- 纳入108例中重度OSA且不耐受PAP治疗的成人,均有治疗前和12个月多导睡眠监测数据。
- 二次分析于2025年6月至11月进行。
主要发现
- 基线缺氧负荷中位数(IQR)为63.4(47.8-96.6)%min/h。
- 治疗12个月后,缺氧负荷中位降低76.6%(33.1%-90.7%)。
- 高缺氧负荷组治疗后缺氧负荷为21.2(7.1-53.8)%min/h,低缺氧负荷组为11.3(6.1-35.9)%min/h。
- 高缺氧负荷组中ESS改善与缺氧负荷降低相关(β=1.25;95%CI,0.02-2.48),与AHI、觉醒指数或传统氧合指标降低无关。
- 高缺氧负荷组(按Sher-20标准36例应答者和18例无应答者)中44例(81.5%)转为低缺氧负荷,包括9例无应答者。
临床怎么用
- 评估舌下神经刺激疗效时,除AHI外可关注缺氧负荷变化。
- 缺氧负荷降低与日间嗜睡改善相关,可作为患者报告结局的生理补充。
- AHI无应答者仍可能从缺氧负荷改善中获益,不应仅凭AHI判定无效。
局限性
- 本研究为二次分析,非随机对照设计。
- 样本以男性为主(84.3%),外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Hypoglossal nerve stimulation has been shown to reduce Apnea-Hypopnea Index (AHI) scores in patients with obstructive sleep apnea (OSA); however, its effect on hypoxic burden (HB), a physiologic marker closely associated with OSA-related risks, remains unclear. OBJECTIVE: To investigate whether hypoglossal nerve stimulation therapy is associated with reduced HB in patients with OSA, and whether any HB reduction improves daytime sleepiness. DESIGN, SETTING, AND PARTICIPANTS: This was a secondary analysis of the Stimulation Therapy for Apnea Reduction (STAR) trial, a multicenter, nonrandomized trial with a randomized withdrawal study, conducted from November 10, 2010, to March 23, 2013. Participants were adults with moderate to severe OSA and intolerant of positive airway pressure therapy. Participants with pretreatment and 12-month polysomnography data available were included in this secondary analysis conducted from June to November 2025. EXPOSURES: Hypoglossal nerve stimulation. MAIN OUTCOMES AND MEASURES: Twelve-month changes in HB after hypoglossal nerve stimulation therapy-ie, HB reduction and proportion of participants transitioning from high (>63 percentage of minutes per hour [%min/h]) to low HB. A secondary outcome was associated HB reduction and improved Epworth Sleepiness Scale (ESS) scores. RESULTS: The analysis included 108 participants (mean [SD] age, 54.5 [10.3] years; 91 [84.3%] male). Baseline median (IQR) HB was 63.4 (47.8-96.6) %min/h. After 12 months of therapy, the median (IQR) percentage HB reduction was 76.6% (33.1%-90.7%). The posttreatment HB was 21.2 (7.1-53.8) %min/h for the high HB group and 11.3 (6.1-35.9) %min/h for the low HB group. In the high HB group, ESS improvement was associated with HB reductions (β = 1.25; 95% CI, 0.02-2.48), but not with reduced AHI, Arousal Index, or traditional oxygen metrics. In the high HB group (36 responders and 18 nonresponders per Sher-20 criteria), 44 participants (81.5%), including 9 nonresponders, transitioned to low HB after hypoglossal nerve stimulation therapy. In the low HB group, all 36 responders retained their low HB; in addition, 11 of 18 nonresponders (61.1%) showed low HB. CONCLUSIONS AND RELEVANCE: In this secondary analysis of the STAR trial, hypoglossal nerve stimulation therapy was signficantly associated with reduced HB in patients with OSA. Daytime sleepiness improvement correlated with HB reduction but not with AHI or Arousal Index changes. Notably, at least half of nonresponders showed marked HB improvement, which suggests that HB may serve as a complementary physiologic marker to AHI for assessing treatment response. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT01161420.
引用
- Xu J, Hajipour Z, Aloia MS, et al. Hypoglossal Nerve Stimulation and Hypoxic Burden in Patients With Obstructive Sleep Apnea: A Secondary Analysis of the STAR Trial. JAMA Otolaryngol Head Neck Surg. 2026. PMID: 42166156. doi:10.1001/jamaoto.2026.1049
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。